InvestorsHub Logo
Followers 27
Posts 887
Boards Moderated 0
Alias Born 12/27/2013

Re: hessmessinc post# 21387

Wednesday, 10/07/2015 8:57:23 AM

Wednesday, October 07, 2015 8:57:23 AM

Post# of 460685
Hess I was apart of that whole debacle and even though they presented results that didn't meet there endpoints the delivering of Stem Cells did in fact beat out the standard of care. So yes they didn't meet there primary endpoints but you didn't tell the whole story. Like they are running another trial reducing the window of time between stroke and getting to the hospital. In fact the Stem Cells did work. Also that study was a blind study. Anavex is open label huge difference.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News